Skyrizi 150 MG/ML penml

Ended Awarded

Contract number
SPE2DR26FAENG
Awardee
Awarding agency
Obligated
$59,090

Award facts

Contract value 100% obligated
$59,089.76 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $59,089.76 delivery order to AmerisourceBergen Drug Corp on May 28, 2026, for SKYRIZI 150 MG/ML (risankizumab injection), with final delivery due May 29, 2026.

This is a firm fixed-price delivery order under the DLA Troop Support Medical indefinite delivery contract. Place of performance is Conshohocken, PA. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., operates as a pharmaceutical distributor supplying brand-name and generic medications, specialty pharmaceuticals, and medical devices to Defense Health Agency and military medical facilities. The order carries no set-aside.

Quick answers

Who was awarded contract SPE2DR26FAENG?

SPE2DR26FAENG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 28, 2026.

How much is contract SPE2DR26FAENG worth?

The government has obligated $59,090 on SPE2DR26FAENG.

Is contract SPE2DR26FAENG an order under another contract?

Yes. SPE2DR26FAENG is a delivery order under SPE2DR25D2011, an indefinite delivery contract.

Was contract SPE2DR26FAENG competed?

The extent of competition for SPE2DR26FAENG was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award